CompaniesGenomeDx Biosciences

GenomeDx Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

5

As Collaborator

1

Total Enrollment

1,000,738

By Phase

NA: 2

By Status

COMPLETED: 5ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
Today
NCT02609269
NCT02783950
Hover over trial bars to see details

Recent Trials

NCT02783950Collaborator
Genomics in Michigan Impacting Observation or Radiation
NACompleted
356 participants
Started: Jan 17, 2017 · Completed: Apr 2, 2024
NCT02609269Lead Sponsor
Decipher Genomics Resource for Intelligent Discovery
N/AEnrolling by invitation
1,000,000 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2040
NCT02080689Lead Sponsor
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
NACompleted
286 participants
Started: May 31, 2014 · Completed: Feb 1, 2017
NCT02034812Lead Sponsor
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
N/ACompleted
25 participants
Started: Jul 31, 2013 · Completed: Jul 31, 2014
NCT02034825Lead Sponsor
Multi-site Decision Impact Study for Decipher
N/ACompleted
50 participants
Started: Jan 31, 2013 · Completed: Jan 31, 2015
View all 6 trials →
Funding History (11)
S-1
Jan 19, 2021
Filing
DRS/A
Dec 4, 2020
Filing
D
May 27, 2020
Filing
DRS/A
Mar 16, 2020
Filing
DRS/A
Jan 15, 2020
Filing
DRS
Nov 14, 2019
Filing
D
Apr 11, 2019
Filing
D
Jan 18, 2019
Filing
D
Oct 9, 2018
Filing
D
Sep 25, 2018
Filing